ArrowMark Colorado Holdings’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
|
|||||
|
2025
Q4 | $391K | Hold |
|
|||||
|
2025
Q3 | $454K | Hold |
|
|||||
|
2025
Q2 | $292K | Sell |
|
|||||
|
2025
Q1 | $2.06M | Sell |
|
|||||
|
2024
Q4 | $4.8M | Buy |
|
|||||
|
2024
Q3 | $7.52M | Buy |
|
|||||
|
2024
Q2 | $5.75M | Sell |
|
|||||
|
2024
Q1 | $10.6M | Sell |
|
|||||
|
2023
Q4 | $12.1M | Sell |
|
|||||
|
2023
Q3 | $4.42M | Buy |
|
|||||
|
2023
Q2 | $852K | Sell |
|
|||||
|
2023
Q1 | $20M | Buy |
|
|||||
|
2022
Q4 | $34.2M | Buy |
|
|||||
|
2022
Q3 | $44.7M | Sell |
|
|||||
|
2022
Q2 | $44.1M | Buy |
|
|||||
|
2022
Q1 | $46.3M | Buy |
|
|||||
|
2021
Q4 | $57.1M | Buy |
|
|||||
|
2021
Q3 | $67.7M | Buy |
|
|||||
|
2021
Q2 | $52.8M | Buy |
|
|||||
|
2021
Q1 | $9.31M | Buy |
|
|||||
|
2020
Q4 | $8.25M | Buy |
|